GB9007971D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9007971D0
GB9007971D0 GB909007971A GB9007971A GB9007971D0 GB 9007971 D0 GB9007971 D0 GB 9007971D0 GB 909007971 A GB909007971 A GB 909007971A GB 9007971 A GB9007971 A GB 9007971A GB 9007971 D0 GB9007971 D0 GB 9007971D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
cyclosporin
another
grafts
rescue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909007971A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imutran Ltd
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Priority to GB909007971A priority Critical patent/GB9007971D0/en
Publication of GB9007971D0 publication Critical patent/GB9007971D0/en
Priority to MYPI91000550A priority patent/MY106158A/en
Priority to ZA912467A priority patent/ZA912467B/xx
Priority to IN265MA1991 priority patent/IN173149B/en
Priority to SG1996001900A priority patent/SG47465A1/en
Priority to AU75555/91A priority patent/AU7555591A/en
Priority to EP91907303A priority patent/EP0527762B1/en
Priority to ES91907303T priority patent/ES2090325T3/es
Priority to AT91907303T priority patent/ATE141167T1/de
Priority to DK91907303.1T priority patent/DK0527762T3/da
Priority to DE69121401T priority patent/DE69121401T2/de
Priority to PCT/GB1991/000522 priority patent/WO1991015221A1/en
Priority to JP50651691A priority patent/JP3518547B2/ja
Priority to IL97788A priority patent/IL97788A/en
Priority to PT97277A priority patent/PT97277B/pt
Priority to IE115391A priority patent/IE911153A1/en
Priority to NZ237739A priority patent/NZ237739A/xx
Priority to CN91102859A priority patent/CN1040178C/zh
Priority to SK988-91A priority patent/SK279949B6/sk
Priority to CS91988A priority patent/CZ283119B6/cs
Priority to GR960403013T priority patent/GR3021642T3/el
Priority to HK48597A priority patent/HK48597A/en
Priority to US09/809,862 priority patent/US20010018051A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB909007971A 1990-04-09 1990-04-09 Pharmaceutical formulations Pending GB9007971D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations
MYPI91000550A MY106158A (en) 1990-04-09 1991-04-02 Inhibition of allograft and concordant xenograft rejection
ZA912467A ZA912467B (en) 1990-04-09 1991-04-03 Inhibition of allograft and concordant xenograft rejection
IN265MA1991 IN173149B (enExample) 1990-04-09 1991-04-03
JP50651691A JP3518547B2 (ja) 1990-04-09 1991-04-04 同種移植および調和異種移植の拒否反応の阻害
DE69121401T DE69121401T2 (de) 1990-04-09 1991-04-04 Hemmung der abstossung bei allogener und concordanter xenogener transplantation
AU75555/91A AU7555591A (en) 1990-04-09 1991-04-04 Inhibition of allograft and concordant xenograft rejection
EP91907303A EP0527762B1 (en) 1990-04-09 1991-04-04 Inhibition of allograft and concordant xenograft rejection
ES91907303T ES2090325T3 (es) 1990-04-09 1991-04-04 Inhibicion de rechazo de aloinjertos y xenoinjertos concordantes.
AT91907303T ATE141167T1 (de) 1990-04-09 1991-04-04 Hemmung der abstossung bei allogener und concordanter xenogener transplantation
DK91907303.1T DK0527762T3 (da) 1990-04-09 1991-04-04 Inhibering af allotransplantat- og konkordant xenotransplantatafstødelse
SG1996001900A SG47465A1 (en) 1990-04-09 1991-04-04 Inhibition of allograft & concordant xenograft rejection
PCT/GB1991/000522 WO1991015221A1 (en) 1990-04-09 1991-04-04 Inhibition of allograft and concordant xenograft rejection
NZ237739A NZ237739A (en) 1990-04-09 1991-04-08 Pharmaceutical composition of a complement inhibitor and an immunosuppressant with cyclosporin a-like activity, and its use
IL97788A IL97788A (en) 1990-04-09 1991-04-08 Pharmaceutical composition comprising a complement inhibitor and an immunosuppressant complete with cyclosporin-a like activity for the inhibition of allograft and concordant xenograft rejection
PT97277A PT97277B (pt) 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
IE115391A IE911153A1 (en) 1990-04-09 1991-04-08 Inhibition of allograft and concordant xenograft rejection
CN91102859A CN1040178C (zh) 1990-04-09 1991-04-09 补体抑制剂用于制备促进移植存活或消除排斥反应的药物
SK988-91A SK279949B6 (sk) 1990-04-09 1991-04-09 Použitie inhibítora komplementu a imunosupresora s
CS91988A CZ283119B6 (cs) 1990-04-09 1991-04-09 Inhibice odhojování alotransplantátů a souhlasných xenotransplantátů
GR960403013T GR3021642T3 (en) 1990-04-09 1996-11-14 Inhibition of allograft and concordant xenograft rejection
HK48597A HK48597A (en) 1990-04-09 1997-04-17 Inhibition of allograft and concordant xenograft rejection
US09/809,862 US20010018051A1 (en) 1990-04-09 2001-03-16 Inhibition of allograft and concordant xenograft rejection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB9007971D0 true GB9007971D0 (en) 1990-06-06

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909007971A Pending GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Country Status (22)

Country Link
EP (1) EP0527762B1 (enExample)
JP (1) JP3518547B2 (enExample)
CN (1) CN1040178C (enExample)
AT (1) ATE141167T1 (enExample)
AU (1) AU7555591A (enExample)
CZ (1) CZ283119B6 (enExample)
DE (1) DE69121401T2 (enExample)
DK (1) DK0527762T3 (enExample)
ES (1) ES2090325T3 (enExample)
GB (1) GB9007971D0 (enExample)
GR (1) GR3021642T3 (enExample)
HK (1) HK48597A (enExample)
IE (1) IE911153A1 (enExample)
IL (1) IL97788A (enExample)
IN (1) IN173149B (enExample)
MY (1) MY106158A (enExample)
NZ (1) NZ237739A (enExample)
PT (1) PT97277B (enExample)
SG (1) SG47465A1 (enExample)
SK (1) SK279949B6 (enExample)
WO (1) WO1991015221A1 (enExample)
ZA (1) ZA912467B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030379A2 (en) * 1999-10-27 2001-05-03 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
JP2004509171A (ja) 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． 炎症及び免疫反応の治療方法及びその組成物
NZ551308A (en) * 2004-05-14 2009-06-26 Alexion Pharma Inc Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
SI3028716T1 (sl) 2006-10-10 2021-01-29 Regenesance B.V. Komplementarna inhibicija za izboljšano regeneracijo živcev
US9447176B2 (en) * 2008-11-10 2016-09-20 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
SI3011345T1 (sl) 2013-08-07 2017-12-29 Alexion Pharmaceuticals, Inc. Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)

Also Published As

Publication number Publication date
ES2090325T3 (es) 1996-10-16
SK279949B6 (sk) 1999-06-11
CZ283119B6 (cs) 1998-01-14
ATE141167T1 (de) 1996-08-15
DE69121401T2 (de) 1996-12-12
JP3518547B2 (ja) 2004-04-12
JPH05507266A (ja) 1993-10-21
DK0527762T3 (da) 1996-09-02
GR3021642T3 (en) 1997-02-28
DE69121401D1 (de) 1996-09-19
IL97788A0 (en) 1992-06-21
EP0527762A1 (en) 1993-02-24
MY106158A (en) 1995-03-31
PT97277B (pt) 1998-08-31
SG47465A1 (en) 1998-04-17
AU7555591A (en) 1991-10-30
IE911153A1 (en) 1991-10-09
CN1056240A (zh) 1991-11-20
IL97788A (en) 1998-02-08
ZA912467B (en) 1992-12-30
IN173149B (enExample) 1994-02-19
NZ237739A (en) 1993-09-27
PT97277A (pt) 1992-01-31
EP0527762B1 (en) 1996-08-14
HK48597A (en) 1997-04-25
CN1040178C (zh) 1998-10-14
CS9100988A2 (en) 1991-12-17
WO1991015221A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
ZA853690B (en) Immunoregulation
AU8764491A (en) Saturated linear polyfluorohydrocarbons, processes for their production, and their use in cleaning compositions
AU3742895A (en) Novel compositions
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
CA2105487A1 (en) Antiviral nucleoside combination
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
EG18379A (en) Novel pharmacological compounds
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
EP0555413A4 (en) Methods and compositions for suppressing allograft rejection in mammals
HU901516D0 (en) The use of s-adenosile-methionine in the treatment of pancreatitis, and in preventing the natural rejection of transplanted pancreas
MY105942A (en) Cyclosporin derivatives.
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
IN173149B (enExample)
CA2120731A1 (en) Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
ZA919808B (en) Anti-herpes castanospermine esters
AU1123001A (en) Compositions and methods for preventing and treating transplant rejection
ZA905422B (en) Substituted 2-imidazolines and preparation and use thereof
Egel et al. Renal failure in heart transplant patients receiving cyclosporine.
ZA892664B (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4-triazoles
IL98644A0 (en) Purified placental derived endothelium cell growth factor and pharmaceutical compositions containing the same
AU7802191A (en) Improvements in and relating to cupboards, shelves and the like
ZA929898B (en) Trestle table for camping and other activities.
PL284247A1 (en) Method for processing full blood, blood plasma and densified blood cells
ES2015997A6 (es) Mejoras en el objeto de la patente n{ 8900026, por procedimiento para la fabricacion de bolsas de malla y bolsas obtenidas con este procedimiento.